{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:00:20Z","timestamp":1771657220994,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s15010-018-1221-6","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T11:28:06Z","timestamp":1537270086000},"page":"307-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["\u2018Lost in Nasal Space\u2019: Staphylococcus aureus sepsis associated with Nasal Handkerchief Packing"],"prefix":"10.1007","volume":"47","author":[{"given":"Philipp","family":"Koehler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Kochanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Lohneis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Shimabukuro-Vornhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-0981","authenticated-orcid":false,"given":"Boris","family":"B\u00f6ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"issue":"8","key":"1221_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJM199808203390806","volume":"339","author":"FD Lowy","year":"1998","unstructured":"Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520\u201332.","journal-title":"N Engl J Med"},{"key":"1221_CR2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/MMBR.27.1.56-71.1963","volume":"27","author":"RE Williams","year":"1963","unstructured":"Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev. 1963;27:56\u201371.","journal-title":"Bacteriol Rev"},{"key":"1221_CR3","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1128\/CDLI.8.6.1064-1069.2001","volume":"8","author":"AM Cole","year":"2001","unstructured":"Cole AM, Tahk S, Oren A, Yoshioka D, Kim YH, Park A, et al. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol. 2001;8:1064\u20139.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1221_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1017\/S0950268800058118","volume":"115","author":"NH Eriksen","year":"1995","unstructured":"Eriksen NH, Espersen F, Rosdahl VT, Jensen K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect. 1995;115:51\u201360.","journal-title":"Epidemiol Infect"},{"key":"1221_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1086\/502426","volume":"25","author":"LA Herwaldt","year":"2004","unstructured":"Herwaldt LA, Cullen JJ, French P, Hu J, Pfaller MA, Wenzel RP, et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol. 2004;25:481\u20134.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1221_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/03014467600001381","volume":"3","author":"CA Armstrong-Esther","year":"1976","unstructured":"Armstrong-Esther CA. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol. 1976;3:221\u20137.","journal-title":"Ann Hum Biol"},{"key":"1221_CR7","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1128\/JCM.41.12.5718-5725.2003","volume":"41","author":"SJ Peacock","year":"2003","unstructured":"Peacock SJ, Justice A, Griffiths D, de Silva GD, Kantzanou MN, Crook D, et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol. 2003;41:5718\u201325.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"1221_CR8","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.1128\/IAI.72.11.6685-6688.2004","volume":"72","author":"J Nouwen","year":"2004","unstructured":"Nouwen J, Boelens H, van Belkum A, Verbrugh H. Human factor in Staphylococcus aureus nasal carriage. Infect Immun. 2004;72(11):6685\u20138.","journal-title":"Infect Immun"},{"key":"1221_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1086\/506401","volume":"27","author":"HF Wertheim","year":"2006","unstructured":"Wertheim HF, van Kleef M, Vos MC, Ott A, Verbrugh HA, Fokkens W. Nose picking and nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol. 2006;27:863\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"1221_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s15010-018-1130-8","volume":"46","author":"N Jung","year":"2018","unstructured":"Jung N, Rieg S. Essentials in the management of S. aureus bloodstream infection. Infection. 2018;46(4):441\u20132. https:\/\/doi.org\/10.1007\/s15010-018-1130-8 .","journal-title":"Infection."},{"key":"1221_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/clinids\/9.5.891","volume":"9","author":"JM Mylotte","year":"1987","unstructured":"Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis. 1987;9:891\u2013907.","journal-title":"Rev Infect Dis"},{"key":"1221_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/512627","volume":"28","author":"S Shurland","year":"2007","unstructured":"Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28:273\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1221_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jinf.2013.10.015","volume":"68","author":"AJ Kaasch","year":"2014","unstructured":"Kaasch AJ, Barlow G, Edgeworth JD, Fowler VG Jr, Hellmich M, Hopkins S, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect. 2014;68:242\u201351.","journal-title":"J Infect"},{"key":"1221_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s15010-017-0997-0","volume":"45","author":"C Lehmann","year":"2017","unstructured":"Lehmann C, Berner R, Bogner JR, Cornely OA, de With K, Herold S, et al. The \u201cChoosing Wisely\u201d initiative in infectious diseases. Infection. 2017;45:263\u20138.","journal-title":"Infection"},{"key":"1221_CR15","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","volume":"163","author":"VG Fowler Jr","year":"2003","unstructured":"Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163:2066\u201372.","journal-title":"Arch Intern Med"},{"key":"1221_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jac\/dku560","volume":"70","author":"AD Bai","year":"2015","unstructured":"Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, et al. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. J Antimicrob Chemother. 2015;70:1539\u201346.","journal-title":"J Antimicrob Chemother"},{"key":"1221_CR17","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1128\/AAC.00485-11","volume":"55","author":"S Lee","year":"2011","unstructured":"Lee S, Choe PG, Song KH, Park SW, Kim HB, Kim NJ, et al. Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia? Antimicrob Agents Chemother. 2011;55:5122\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1221_CR18","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1128\/AAC.02800-14","volume":"58","author":"J Li","year":"2014","unstructured":"Li J, Echevarria KL, Hughes DW, Cadena JA, Bowling JE, Lewis JS. 2nd. Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2014;58:5117\u201324.","journal-title":"Antimicrob Agents Chemother"},{"key":"1221_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/cid\/cis889","volume":"56","author":"E Forsblom","year":"2013","unstructured":"Forsblom E, Ruotsalainen E, Ollgren J, Jarvinen A. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus Bacteremia. Clin Infect Dis. 2013;56:527\u201335.","journal-title":"Clin Infect Dis"},{"key":"1221_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s15010-016-0919-6","volume":"45","author":"D Yahav","year":"2017","unstructured":"Yahav D, Shaked H, Goldberg E, Yassin S, Eliakim-Raz N, Paul M, et al. Time trends in Staphylococcus aureus bacteremia, 1988\u20132010, in a tertiary center with high methicillin resistance rates. Infection. 2017;45:51\u20137.","journal-title":"Infection"},{"key":"1221_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/SAP.0000000000000817","volume":"76","author":"EA Roberts","year":"2016","unstructured":"Roberts EA, Troiano C, Spiegel JH. Standardization of guidelines for patient photograph deidentification. Ann Plast Surg. 2016;76:611\u20134.","journal-title":"Ann Plast Surg"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-018-1221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-018-1221-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-018-1221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T04:17:41Z","timestamp":1604981861000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-018-1221-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1221"],"URL":"https:\/\/doi.org\/10.1007\/s15010-018-1221-6","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"PK reports non-financial support from Merck\/MSD, non-financial support from MedImmune, and lecture honoraria from Astellas outside the submitted work. NJ received lecture fees from Labor Stein, Novartis, Gilead, MSD, Infectopharm and travel grants from Novartis, Pfizer, Astellas, Basilea, Gilead. MK declares no potential conflict of interest in regard to this work. PL declares no potential conflict of interest in regard to this work. ASV declares no potential conflict of interest in regard to this work. BB declares no potential conflict of interest in regard to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}